Internal Medicine, Hematology & Oncology · Bloomfield, NJ
NPI
1659530608
Since 2008
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
2
Medicare group memberships
Hospitals
5
Hospital affiliations
1515 Broad St Ste B120
Bloomfield, NJ, 07003
Phone (973) 873-7000
Groups this clinician bills Medicare through
Medicare paid, 2024
$3.2M
98,751 services
Medicare patients, 2024
540
Average age 77
Drug cost, 2024
$15.8M
4,020 prescriptions
Company payments, 2025
$14K
From 9 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Elan Diamond was code J9177 (injection, enfortumab vedotin-ejfv, 0.25 mg), 35,168 times for 15 patients. In total Elan Diamond billed 98,751 services in 102 codes, and Medicare paid $3.2M.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2022-06-06.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J9177 Injection, enfortumab vedotin-ejfv, 0.25 mg | Office | 35,168 | 15 | $28.61 | $1.0M |
| J9271 Injection, pembrolizumab, 1 mg | Office | 14,400 | 17 | $44.90 | $647K |
| J9171 Injection, docetaxel, 1 mg | Office | 7,665 | 21 | $0.69 | $5,270 |
| J0897 Injection, denosumab, 1 mg | Office | 5,580 | 21 | $20.44 | $114K |
| J0185 Injection, aprepitant, 1 mg | Office | 3,640 | 12 | $1.27 | $4,638 |
| J9043 Injection, cabazitaxel, 1 mg | Office | 2,760 | 12 | $168.01 | $464K |
| J1100 Injection, dexamethasone sodium phosphate, 1 mg | Office | 1,534 | 32 | $0.09 | $136 |
| 99214 Office E&M - Established | Office | 1,150 | 419 | $105.41 | $121K |
| J2405 Injection, ondansetron hydrochloride, per 1 mg | Office | 1,084 | 26 | $0.07 | $79.85 |
| J2506 Injection, pegfilgrastim, excludes biosimilar, 0.5 mg | Office | 804 | 24 | $47.14 | $38K |
| 36415 Venipuncture Blood Collection | Office | 554 | 205 | $8.64 | $4,786 |
| J9201 Injection, gemcitabine hydrochloride, not otherwise specified, 200 mg | Office | 539 | 18 | $2.56 | $1,380 |
| 99215 Office E&M - Established | Office | 491 | 222 | $151.59 | $74K |
| 96375 Injection Administration | Office | 453 | 49 | $13.47 | $6,101 |
| 80053 Clinical Chemistry | Office | 420 | 168 | $10.11 | $4,248 |
By year: 2022 $2.3M for 101,165 services; 2023 $2.9M for 107,703 services; 2024 $3.2M for 98,751 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 554 | 205 | $8.64 | $4,786 |
| 80053 Clinical Chemistry | 420 | 168 | $10.11 | $4,248 |
| 85025 Blood Count | 372 | 153 | $7.43 | $2,765 |
| 84153 Clinical Chemistry | 264 | 146 | $17.54 | $4,631 |
| 84403 Clinical Chemistry | 132 | 102 | $24.74 | $3,265 |
| 80061 Clinical Chemistry | 97 | 80 | $12.87 | $1,248 |
| 82533 Clinical Chemistry | 96 | 22 | $15.97 | $1,533 |
| 83036 Blood Count | 91 | 75 | $9.32 | $848 |
| 84443 Clinical Chemistry | 77 | 26 | $16.46 | $1,267 |
| 83540 Clinical Chemistry | 14 | 13 | $6.34 | $88.76 |
Medicare prescription drug claims, 2024
In 2024, the drug Elan Diamond prescribed most often to Medicare patients was Prednisone, with 862 prescriptions and refills. In total Elan Diamond wrote 4,020 Medicare prescriptions that cost $15.8M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Prednisone Generic | 862 | 934 | 153 | $3,540 |
| Nubeqa Darolutamide | 812 | 820 | 109 | $10.3M |
| Abiraterone Acetate Generic | 735 | 747 | 110 | $1.3M |
| Orgovyx Relugolix | 307 | 307 | 34 | $814K |
| Megestrol Acetate Generic | 173 | 219 | 72 | $8,157 |
| Xtandi Enzalutamide | 159 | 159 | 25 | $2.1M |
| Potassium Chloride Generic | 77 | 99 | 22 | $551 |
| Pantoprazole Sodium Generic | 69 | 117 | 27 | $743 |
| Amlodipine Besylate Generic | 60 | 94 | 19 | $169 |
| Alendronate Sodium Generic | 53 | 84 | 11 | $334 |
| Atorvastatin Calcium Generic | 42 | 65 | 11 | $306 |
| Dexamethasone Generic | 40 | 40 | 15 | $662 |
| Erleada Apalutamide | 39 | 41 | Under 11 | $584K |
| Zolpidem Tartrate Generic | 32 | 32 | 13 | $93.88 |
| Escitalopram Oxalate Generic | 31 | 44 | 12 | $111 |
Brand drugs: 1,395 claims; generic drugs: 2,625 claims; opioid claims: 76.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Elan Diamond $14K ($14K in general payments such as food, travel and fees) from 9 companies. The largest payer was Bayer Healthcare Pharmaceuticals Inc. with $4,118.
| Company | Payments | Amount |
|---|---|---|
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 4 | $4,118 |
| AstraZeneca Pharmaceuticals LP AZN | 2 | $3,367 |
| Janssen Biotech, Inc. JNJ | 2 | $2,803 |
| Eisai Inc. 4523.T | 1 | $1,538 |
| Merck Sharp & Dohme LLC MRK | 1 | $1,520 |
| Janssen Scientific Affairs, LLC JNJ | 1 | $880 |
| Novartis Pharmaceuticals Corporation NVS | 1 | $20.37 |
| Kerecis Limited | 1 | $19.59 |
| Adaptive Biotechnologies Corporation ADPT | 1 | $16.42 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.